Short answer · Medically reviewed summary · Last updated: 2026-04-07
Sandhoff disease is classified under the ICD-10 code E75.02 (Sandhoff disease) and historically under the ICD-9 code 330.1 (Tay-Sachs disease, which includes Sandhoff disease as a variant). These codes are used by healthcare providers and insurance systems to specifically identify and track the diagnosis of this rare, progressive neurodegenerative disorder. What is the clinical classification of Sandhoff disease? Sandhoff disease is a rare lysosomal storage disorder characterized by the progressive destruction of nerve cells in the brain and spinal cord.
ICD10 code of Sandhoff Disease and ICD9 code
ICD-10 and ICD-9 codes for Sandhoff Disease, with classification details for clinicians, coders and patients.
Sandhoff disease is classified under the ICD-10 code E75.02 (Sandhoff disease) and historically under the ICD-9 code 330.1 (Tay-Sachs disease, which includes Sandhoff disease as a variant). These codes are used by healthcare providers and insurance systems to specifically identify and track the diagnosis of this rare, progressive neurodegenerative disorder.
What is the clinical classification of Sandhoff disease?
Sandhoff disease is a rare lysosomal storage disorder characterized by the progressive destruction of nerve cells in the brain and spinal cord. Medically, it is classified as a GM2 gangliosidosis. Because Sandhoff disease shares many clinical features with Tay-Sachs disease—specifically the accumulation of GM2 gangliosides due to a deficiency in the enzyme beta-hexosaminidase—they are often grouped together in older diagnostic coding systems. However, Sandhoff disease is distinct because it involves a deficiency in both the hexosaminidase A and B subunits, whereas Tay-Sachs involves only the A subunit.
How is Sandhoff disease diagnosed and coded?
Diagnosis of Sandhoff disease typically involves biochemical testing to measure hexosaminidase enzyme activity in blood or skin cells, followed by molecular genetic testing to identify mutations in the HEXB gene. Once confirmed, clinicians use the ICD-10 code E75.02 to ensure accurate medical record-keeping. Proper coding is vital for patients, as it helps facilitate access to specialized care and clinical resources. Within the DiseaseMaps.org community, 44 people with Sandhoff disease have shared their experiences, highlighting the importance of standardized diagnostic paths for rare disease navigation.
Is Sandhoff disease hereditary?
Yes, Sandhoff disease is an inherited condition with an autosomal recessive pattern of inheritance. This means that for a child to be born with the condition, both biological parents must be carriers of a mutated HEXB gene. When both parents are carriers, there is a 25% chance with each pregnancy that the child will inherit the disorder. Genetic counseling is strongly recommended for families who have received a diagnosis or who have a family history of Sandhoff disease to discuss reproductive options and carrier screening.
What are the primary clinical features of Sandhoff disease?
The clinical presentation of Sandhoff disease can vary based on the age of onset, which is generally categorized into infantile, juvenile, and adult forms. Common manifestations include:
- Infantile form: Typically appears in the first 6 months of life, characterized by exaggerated startle response, developmental regression, and cherry-red spots in the retina.
- Neurological decline: Progressive loss of motor skills, intellectual impairment, and seizures.
- Systemic involvement: Unlike Tay-Sachs, Sandhoff disease often involves organomegaly (enlarged liver and spleen) and skeletal abnormalities.
- Muscle weakness: Progressive atrophy and loss of muscle tone (hypotonia) or spasticity.
Next steps
- Consult a metabolic specialist or a pediatric neurologist to confirm the diagnosis and establish a multidisciplinary care plan.
- Request a referral to a genetic counselor to discuss family testing and recurrence risks.
- Connect with the 44 members of the DiseaseMaps.org community to share support and practical disease management strategies.
- Monitor clinical trial registries like ClinicalTrials.gov for research updates on enzyme replacement therapies or gene therapy approaches.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.
